ISSCR Joins Coalition Letter to Support 5% Increase in NIH Funding for FY 2024

The ISSCR is among 373 members of the Ad Hoc Group for Medical Research who signed a joint letter in support robust funding for the National Institutes of Health (NIH). For fiscal year (FY) 2024, the Ad Hoc Group recommends at least $50.924 billion for NIH’s foundational work, a $3.465 billion increase over the comparable FY 2023 program level, which would allow NIH’s base budget to keep pace with the biomedical research and development price index (BRDPI) and allow meaningful growth of nearly 5%. The letter also underscores that the federal investment in this lifesaving work in labs across the country has a multiplier effect in local and regional economies, catalyzes new industries, enhances the U.S.’s global competitiveness, establishes viable career paths, and generates additional high quality jobs in communities nationwide.

The Ad Hoc Group includes organizations representing patients, scientists, health professionals, research and academic institutions, educators, and industry.

Read the letter.

Previous
Previous

Chen Institute Partners with ISSCR to Establish Fellowship for Stem Cell Reports Early Career Editorial Board

Next
Next

ISSCR Guidelines Update Now Available in Japanese